Risk of esophagus cancer in diabetes mellitus: A population-based case-control study in Taiwan

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Cheng, Kao Chi ^a   Chen, Yu Lung ^a   Lai, Shih Wei ^a,b   Tsai, Pang Yao ^a,c   Sung, Fung Chang ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Case control study; Diabetes; Esophagus cancer; Insulin

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; INSULIN; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ALCOHOLISM; ARTICLE; CANCER RISK; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG RESPONSE; ESOPHAGUS CANCER; ESOPHAGUS ULCER; EXPERIMENTAL DESIGN; FEMALE; GASTROESOPHAGEAL REFLUX; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ALCOHOLISM; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CYCLOOXYGENASE 2 INHIBITORS; DIABETES MELLITUS; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SULFONYLUREA COMPOUNDS; TAIWAN; ULCER; YOUNG ADULT;

EID: 84870859677     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-177     Document Type: Article

References (49)

1. Zhan YS, Feng L, Tang SH, Li WG, Xu M, Liu TF, Zhou YF, Ma YL, Zhang Y, Pu XM. Glucose metabolism disorders in cancer patients in a Chinese population. Med Oncol 2010, 27(2):177-184. 10.1007/s12032-009-9189-9, 19263254.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053. 10.2337/diacare.27.5.1047, 15111519.
3. Chang C, Lu F, Yang YC, Wu JS, Wu TJ, Chen MS, Chuang LM, Tai TY. Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract 2000, 50(Suppl 2):S49-S59.
4. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005, 293:194-202. 10.1001/jama.293.2.194, 15644546.
5. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005, 54(4):533-539. 10.1136/gut.2004.052167, 1774454, 15753540.
6. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006, 166(17):1871-1877. 10.1001/archinte.166.17.1871, 17000944.
7. Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 2006, 49(12):2819-2823. 10.1007/s00125-006-0468-0, 17021919.
8. Huang W, Ren H, Ben Q, Cai Q, Zhu W, Li Z. Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies. Canc Causes Contr 2012, 23(2):263-272.
9. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 2003, 26(6):1752-1758. 10.2337/diacare.26.6.1752, 12766105.
10. Saltzman BS, Doherty JA, Hill DA, Beresford SA, Voigt LF, Chen C, Weiss NS. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 2008, 167(5):607-614.
11. Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev 2007, 16(1):83-89. 10.1097/01.cej.0000228404.37858.40, 17220709.
12. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991, 265(10):1287-1289. 10.1001/jama.1991.03460100089030, 1995976.
13. Wayman J, Forman D, Griffin SM. Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry. Canc Causes Contr 2001, 12(10):943-949.
14. Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol 2005, 92(3):151-159. 10.1002/jso.20357, 16299786.
15. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005, 97(2):142-146. 10.1093/jnci/dji024, 15657344.
16. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002, 50(3):368-372. 10.1136/gut.50.3.368, 1773122, 11839716.
17. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 2007, 17(1):2-9. 10.1016/j.semradonc.2006.09.003, 17185192.
18. Chang SS, Lu CL, Chao JY, Chao Y, Yen SH, Wang SS, Chang FY, Lee SD. Unchanging trend of adenocarcinoma of the esophagus and gastric cardia in Taiwan: A 15-year experience in a single center. Digest Dis Sci 2002, 47(4):735-740. 10.1023/A:1014771429546, 11991601.
19. Cheng TM. Taiwan's national health insurance system: High value for the dollar. Six Countries, Six Reform Models: the Healthcare Reform 2010, 171-204. Experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan: Healthcare Reforms" under the Radar Screen".
20. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore) 2010, 89(5):295-299.
21. Lai SW, Muo CH, Liao KF, Sung FC, Chen PC. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol 2011, 106(9):1697-1704. 10.1038/ajg.2011.155, 21577242.
22. Lai SW, Su LT, Lin CH, Tsai CH, Sung FC, Hsieh DP. Polypharmacy increases the risk of Parkinson's disease in older people in Taiwan: a population-based study. Psychogeriatrics 2011, 11(3):150-156. 10.1111/j.1479-8301.2011.00369.x, 21951955.
23. Jiang X, Bernstein L, Tseng CC, Wu AH. Diabetes and risk of esophageal and gastric adenocarcinomas. Int J Cancer 2012, 131(6):1417-1422. 10.1002/ijc.27390, 22161620.
24. Rubenstein JH, Davis J, Marrero JA, Inadomi JM. Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia. Aliment Pharmacol Ther 2005, 22(3):267-271. 10.1111/j.1365-2036.2005.02544.x, 16091065.
25. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011, 128(3):635-643. 10.1002/ijc.25362, 2962873, 20473855.
26. Islami F, Fedirko V, Tramacere I, Bagnardi V, Jenab M, Scotti L, Rota M, Corrao G, Garavello W, Schüz J, Straif K, Negri E, Boffetta P, La Vecchia C. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer 2011, 129(10):2473-2484. 10.1002/ijc.25885, 21190191.
27. Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption. PLoS Med 2009, 6(3):e50. 10.1371/journal.pmed.1000050, 2659709, 19320537.
28. Seow A, Yuan JM, Koh WP, Lee HP, Yu MC. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst 2006, 98(2):135-138. 10.1093/jnci/djj015, 16418516.
29. Calton BA, Chang SC, Wright ME, Kipnis V, Lawson K, Thompson FE, Subar AF, Mouw T, Campbell DS, Hurwitz P, et al. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Canc Causes Contr 2007, 18(5):493-503.
30. Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008, 134(1):95-101. 10.1053/j.gastro.2007.10.040, 2271041, 18061176.
31. Perrin MC, Terry MB, Kleinhaus K, Deutsch L, Yanetz R, Tiram E, Calderon-Margalit R, Friedlander Y, Paltiel O, Harlap S. Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study. Breast Cancer Res Treat 2008, 108(1):129-135. 10.1007/s10549-007-9585-9, 17476589.
32. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 2008, 109(2):389-395. 10.1007/s10549-007-9654-0, 17659440.
33. Holroyde CP, Skutches CL, Boden G, Reichard GA. Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res 1984, 44(12 Pt 1):5910-5913.
34. Blot WJ. Alcohol and cancer. Cancer Res 1992, 52(7 Suppl):2119s-2123s.
35. Ji BT, Dai Q, Gao YT, Hsing AW, McLaughlin JK, Fraumeni JF, Chow WH. Cigarette and alcohol consumption and the risk of colorectal cancer in Shanghai, China. Eur J Cancer Prev 2002, 11(3):237-244. 10.1097/00008469-200206000-00007, 12131657.
36. La Vecchia C. Alcohol and liver cancer. Eur J Cancer Prev 2007, 16(6):495-497. 10.1097/CEJ.0b013e3280145b5d, 18090120.
37. Vioque J, Barber X, Bolumar F, Porta M, Santibanez M, de la Hera MG, Moreno-Osset E. Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain. BMC Cancer 2008, 8:221-230. 10.1186/1471-2407-8-221, 2529333, 18673563.
38. Fan Y, Yuan JM, Wang R, Gao YT, Yu MC. Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study. Nutr Cancer 2008, 60(3):354-363. 10.1080/01635580701883011, 2409004, 18444169.
39. Morita M, Kumashiro R, Kubo N, Nakashima Y, Yoshida R, Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Sakaguchi Y, Toh Y, Maehara Y. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol 2010, 15(2):126-134. 10.1007/s10147-010-0056-7, 20224884.
40. Kort EJ, Sevensma E, Fitzgerald TL. Trends in esophageal cancer and body mass index by race and gender in the state of Michigan. BMC Gastroenterol 2009, 9:47-53. 10.1186/1471-230X-9-47, 2708181, 19545449.
41. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001, 92(3):549-555. 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L, 11505399.
42. Zhang HY, Spechler SJ, Souza RF. Esophageal adenocarcinoma arising in Barrett esophagus. Cancer Lett 2009, 275(2):170-177. 10.1016/j.canlet.2008.07.006, 2673195, 18703277.
43. Schottenfeld D, Beebe-Dimmer J. Alleviating the burden of cancer: a perspective on advances, challenges, and future directions. Cancer Epidemiol Biomarkers Prev 2006, 15(11):2049-2055. 10.1158/1055-9965.EPI-06-0603, 17119027.
44. Harris EL. Association of oral cancers with alcohol consumption: exploring mechanisms. J Natl Cancer Inst 1997, 89(22):1656-1657. 10.1093/jnci/89.22.1656, 9390529.
45. Homann N, Karkkainen P, Koivisto T, Nosova T, Jokelainen K, Salaspuro M. Effects of acetaldehyde on cell regeneration and differentiation of the upper gastrointestinal tract mucosa. J Natl Cancer Inst 1997, 89(22):1692-1697. 10.1093/jnci/89.22.1692, 9390538.
46. Purdy JK, Appelman HD, McKenna BJ. Sloughing esophagitis is associated with chronic debilitation and medications that injure the esophageal mucosa. Mod Pathol 2012, [Epub ahead of print]..
47. García Rodríguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006, 55(11):1538-44. Epub 2006 Jun 19., 10.1136/gut.2005.086579, 1860118, 16785284.
48. Ljung R, Martin L, Lagergren J. Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden. Eur J Cancer 2011, 47(14):2128-2132. 10.1016/j.ejca.2011.03.012, 21489778.
49. Uno K, Iijima K, Hatta W, Koike T, Abe Y, Asano N, Kusaka G, Shimosegawa T. Direct measurement of gastroesophageal reflux episodes in patients with squamous cell carcinoma by 24-h pH-impedance monitoring. Am J Gastroenterol 2011, 106(11):1923-1929. 10.1038/ajg.2011.282, 21931379.